Provided is a curable composition that has a sufficient pot life and does not cause a significant delay in curing time even after long-term storage at room temperature or higher. A separately packed curable composition includes: (A) a first pack containing: (a1) a polymerizable monomer having no acidic group, (b) a polymerizable monomer having an acidic group, and (c) a transition metal compound; and (B) a second pack containing: (a2) a polymerizable monomer having no acidic group, (d) an aromatic amine compound, and (e) at least one compound selected from sulfinic acid and a salt thereof.

A dental glass powder includes 15 to 40% by mass of zinc oxide (ZnO), 20 to 55% by mass of silicon oxide (SiO.sub.2), 6 to 20% by mass of aluminum oxide (Al.sub.2O.sub.3), 1 to 13% by mass of calcium oxide (CaO), and 1 to 19% by mass of fluorine (F).

A dental glass powder includes 15 to 40% by mass of zinc oxide (ZnO), 20 to 55% by mass of silicon oxide (SiO.sub.2), 6 to 20% by mass of aluminum oxide (Al.sub.2O.sub.3), 1 to 13% by mass of calcium oxide (CaO), and 1 to 19% by mass of fluorine (F).

A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.

A biocompatible composite material for controlled release is disclosed, comprising a biocompatible metal oxide structure with a loaded network of pores. The pore network of the biocompatible composite material is filled with a uniformly distributed biologically active micellizing amphiphilic molecule, the size of these pores ranging from about 0.5 to about 100 nanometers. The material is characterized in that when exposed to phosphate-buffered saline (PBS), the controlled release of the active amphiphilic molecule is predominantly diffusion-driven over time.

The present invention relates to a dental composition including cement and a non-aqueous liquid, wherein the cement includes a first domain including alite, a second domain including belite, and a matrix located between one or more selected from the group consisting of the first domain and the second domain and configured to include silicon (Si)-atom-doped tricalcium aluminate (3CaO.Al.sub.2O.sub.3). A dental hydraulic composition according to the present invention is a single ointment-type composition, and is thus easy to use and exhibits a good aesthetic appearance, high curability and high biocompatibility.

The present invention relates to a dental composition including cement and a non-aqueous liquid, wherein the cement includes a first domain including alite, a second domain including belite, and a matrix located between one or more selected from the group consisting of the first domain and the second domain and configured to include silicon (Si)-atom-doped tricalcium aluminate (3CaO.Al.sub.2O.sub.3). A dental hydraulic composition according to the present invention is a single ointment-type composition, and is thus easy to use and exhibits a good aesthetic appearance, high curability and high biocompatibility.

Provided is a curable composition that has a sufficient pot life and does not cause a significant delay in curing time even after long-term storage at room temperature or higher. A separately packed curable composition includes: (A) a first pack containing: (a1) a polymerizable monomer having no acidic group, (b) a polymerizable monomer having an acidic group, and (c) a transition metal compound; and (B) a second pack containing: (a2) a polymerizable monomer having no acidic group, (d) an aromatic amine compound, and (e) at least one compound selected from sulfinic acid and a salt thereof.

Provided is a curable composition that has a sufficient pot life and does not cause a significant delay in curing time even after long-term storage at room temperature or higher. A separately packed curable composition includes: (A) a first pack containing: (a1) a polymerizable monomer having no acidic group, (b) a polymerizable monomer having an acidic group, and (c) a transition metal compound; and (B) a second pack containing: (a2) a polymerizable monomer having no acidic group, (d) an aromatic amine compound, and (e) at least one compound selected from sulfinic acid and a salt thereof.

Disclosed is a medical filler composition, which is loaded in a space which is empty due to the removal of nerves, blood vessels, cell tissues and hard tissues therefrom and which is also biocompatible, highly bioactive and biochemically stable and has high workability and sealing ability, including a calcium supply source including at least one selected from among calcium hydroxide and calcium oxide, a silicon supply source including at least one selected from fumed silica, precipitated silica, colloidal silica and clay mineral, and 20 to 70 parts by weight of a liquid material for pasting, based on 100 parts by weight of a mixture of the calcium supply source and the silicon supply source, wherein the calcium/silicon molar ratio of calcium silicate hydrate produced by a pozzolanic reaction between the calcium supply source and the silicon supply source is 0.25 to 1.5.